Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.
Crosignani, S., Bingham, P., Bottemanne, P., Cannelle, H., Cauwenberghs, S., Cordonnier, M., Dalvie, D., Deroose, F., Feng, J.L., Gomes, B., Greasley, S., Kaiser, S.E., Kraus, M., Negrerie, M., Maegley, K., Miller, N., Murray, B.W., Schneider, M., Soloweij, J., Stewart, A.E., Tumang, J., Torti, V.R., Van Den Eynde, B., Wythes, M.
J. Med. Chem.